Literature DB >> 14169457

BASAL COPPER EXCRETION IN WILSON'S DISEASE.

C B WARREN, P M BROUGHTON.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; CHILD; COPPER; DRUG THERAPY; HEPATOLENTICULAR DEGENERATION; PENICILLAMINE; URINE

Mesh:

Substances:

Year:  1964        PMID: 14169457      PMCID: PMC2019214          DOI: 10.1136/adc.39.205.265

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  7 in total

1.  Wilson's disease.

Authors:  C B WARREN; P M BROUGHTON
Journal:  Arch Dis Child       Date:  1962-06       Impact factor: 3.791

2.  The diagnosis of Wilson's disease in asymptomatic patients.

Authors:  I STERNLIEB; I H SCHEINBERG
Journal:  JAMA       Date:  1963-03-02       Impact factor: 56.272

3.  Treatment of Wilson's disease with penicillamine.

Authors:  J M WALSHE
Journal:  Lancet       Date:  1960-01-23       Impact factor: 79.321

4.  Effect of estrogens on copper metabolism in Wilson's disease.

Authors:  J L GERMAN; A G BEARN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

5.  Screening test for excessive urinary copper.

Authors:  C J EARL
Journal:  Lancet       Date:  1954-01-30       Impact factor: 79.321

6.  Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria.

Authors:  A G BEARN; H G KUNKEL
Journal:  J Clin Invest       Date:  1954-03       Impact factor: 14.808

7.  The metabolic disorder in hepato-lenticular degeneration.

Authors:  W B MATTHEWS; M D MILNE; M BELL
Journal:  Q J Med       Date:  1952-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.